Clinical Trials in Zhangzhou, Fujian
42 recruiting
Showing 1–20 of 28 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb750 enrolled271 locationsNCT07361510
Recruiting
Phase 3
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
HER2-positive Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.544 enrolled78 locationsNCT07043725
Recruiting
Phase 2
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Fujian Cancer Hospital89 enrolled14 locationsNCT07256236
Recruiting
Phase 3
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Small Cell Lung Cancer
Akeso560 enrolled53 locationsNCT07010263
Recruiting
Not Applicable
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
Atrial FibrillationIschemic Stroke
Capital Medical University240 enrolled37 locationsNCT07139314
Recruiting
Not Applicable
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
Atrial FibrillationIschemic Stroke
Capital Medical University438 enrolled40 locationsNCT07139301
Recruiting
Not Applicable
A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
Renal Anemia of Chronic Kidney Disease
Guangdong Provincial People's Hospital96 enrolled24 locationsNCT07136792
Recruiting
Phase 3
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Takeda402 enrolled36 locationsNCT03221036
Recruiting
Phase 3
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Acute Ischemic StrokeCerebral Infarction
Capital Medical University1,184 enrolled71 locationsNCT06548971
Recruiting
Phase 2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital25 enrolled12 locationsNCT07296705
Recruiting
Phase 3
Normobaric Oxygen in AIS Transferred for EVT
Ischemic Stroke
Capital Medical University1,500 enrolled112 locationsNCT06666764
Recruiting
Phase 3
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）
Acute Ischemic StrokeAnterior Circulation Brain Infarction
Capital Medical University2,105 enrolled56 locationsNCT06559241
Recruiting
POASAC Study (Preoperative Anemia Severity and Classification Study)
Anemia
Peking Union Medical College Hospital1,000 enrolled11 locationsNCT06499974
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979
Recruiting
Not Applicable
Balloon Guide Catheter to Optimize Outcomes in Stroke Thrombectomy of the Internal Carotid Artery
Stroke
Xuanwu Hospital, Beijing364 enrolled3 locationsNCT07192029
Recruiting
Phase 2
Efficacy and Safety of SR1375 in Adult Patients With CAP
Community-acquired Pneumonia
Shanghai SIMR Biotechnology Co., Ltd.240 enrolled29 locationsNCT06577558
Recruiting
Phase 2
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
ChemotherapyPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University208 enrolled3 locationsNCT06811844
Recruiting
A Study of Enterorenal Syndrome Assessed by Gastrointestinal Ultrasound Combined with Renal Artery Resistance Index
SepsisUrinary Tract Infections
Zhangzhou Municipal Hospital74 enrolled1 locationNCT06505512
Recruiting
Phase 1Phase 2
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
Metastatic Pancreatic CancerLocally Advanced Pancreatic Cancer
Fujian Provincial Hospital29 enrolled4 locationsNCT06761027
Recruiting
Prospective Cohort of Patients With Intracerebral Hemorrhage
Stroke, AcuteIntracerebral Hemorrhage
De-zhi Kang3,000 enrolled6 locationsNCT06670456